NCT00619216View on ClinicalTrials.gov

Myfortic Conversion Trial in OLT Recipients With GI Intolerance

CompletedOBSERVATIONAL

Enrollment

31

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

GI Disturbance

Interventions

DRUG

Mycophenolic Acid (Myfortic)

Equimolar conversion from mycophenolate mofetil to mycophenolic acid

Trial Locations (1)

27599-7211

University of North Carolina-Chapel Hill, Chapel Hill

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER